RAYMOND JAMES & ASSOCIATES - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 23 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$14,854
+1.8%
15,0000.0%0.00%
Q4 2022$14,597
-2.7%
15,0000.0%0.00%
Q3 2022$15,000
+7.1%
15,0000.0%0.00%
Q2 2022$14,000
-6.7%
15,0000.0%0.00%
Q1 2022$15,0000.0%15,0000.0%0.00%
Q4 2021$15,0000.0%15,0000.0%0.00%
Q3 2021$15,00015,0000.00%
Other shareholders

There were no reported owners of LIGAND PHARMACEUTICALS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of LIGAND PHARMACEUTICALS INC shareholders